The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...

“There is no evidence to say that leucovorin will help most people with autism, and there’s certainly no evidence to say it’s safe,” said Dr. Alycia Halladay of the Autism Science Foundation, in an ...

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...

A comprehensive new study suggests that females require a much larger biological and cognitive shift to develop autism than males do. The findings help explain why the condition is diagnosed ...

Autism is a developmental condition that affects how people communicate, learn, and interact with others. It usually appears ...

Long-read genome sequencing reveals autism gene variants and structural changes, helping explain missing heritability and advancing precision diagnostics.

Researchers developed brain organoids from patient samples to model genetic subtypes of autism spectrum disorders (ASD), creating a translational platform that better reflects the human-specific ...

Researchers are reacting to the FDA's decision not to approve the prescription drug leucovorin for the treatment of autism.

The FDA narrowed leucovorin's use to a rare disorder, a major shift after Trump and RFK Jr. promoted it for autism.

The drug leucovorin was touted by the Trump administration in September as a potential treatment for thousands of children with autism. Now, some parents and guardians of children with autism say they ...

Robert F. Kennedy Jr., the United States Secretary of Health and Human Services, earlier claimed that the drug leucovorin ...

The FDA on Tuesday approved leucovorin as a treatment for a rare genetic condition, not for autism, as the Trump administration had suggested ...